Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Galcanezumab in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of [¹⁴C]-LY3023414 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Mirikizumab (LY3074828) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE1
A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of [¹⁴C]-LY3202626 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2